La nécessité de délivrer des médicaments directement dans les cellules est grandissante avec le développement des thérapies géniques. Les peptides pénétrants (Cell Penetrating Peptides : CPP) représentent une possibilité pour administrer ces médicaments dans les cellules sans effet délétère sur la membrane. Ce sont des peptides d’une dizaine d’acides aminés, généralement cationiques. Ils sont capables de traverser la membrane cellulaire, et conservent cette propriété lorsqu’une cargaison leur est attachée. Cependant, leurs mécanismes d’entrée ne sont toujours pas tous connus. Nous avons caractérisé quelques aspects des mécanismes permettant aux CPP de traverser directement la membrane plasmique à l’aide de trois techniques biophysiques. i) ...
Cell-penetrating peptides can cross cell membranes and deliver biologically active molecules into ce...
Before discovery of the Tat peptide over twenty years ago, it was assumed that large peptides and pr...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Faire traverser une membrane cellulaire à des molécules bioactives est un enjeu majeur dans des pers...
International audienceThe ability of cell penetrating peptides (CPPs) to cross cell membranes has fo...
Cell Penetrating Peptides (CPPs) are known to be able to cross cell membranes with a cargo through t...
Les peptides vecteurs se caractérisent par leur capacité à traverser les membranes cellulaires. Ils ...
Cell penetrating peptides (CPPs) are short peptides able to efficiently cross cellular membrane. The...
Cell-penetrating peptides (CPP) are cationic oligopeptides currently investigated as potential vecto...
This document is the Accepted Manuscript version of a Published Work that appeared in final form in ...
Cell-penetrating peptides (CPPs) allow intracellular delivery of bioactive cargo molecules. The mech...
Cell penetrating peptides (CPPs) have been successfully used to mediate the intracellular delivery o...
Many biologically active compounds, including macromolecules that are used as various kinds of drugs...
Cell Penetrating Peptides (CPPs) are short amino acid sequences that are able to traverse the cell m...
Cell penetrating peptides (CPPs) are an increasingly growing part of fundamental and applied peptide...
Cell-penetrating peptides can cross cell membranes and deliver biologically active molecules into ce...
Before discovery of the Tat peptide over twenty years ago, it was assumed that large peptides and pr...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Faire traverser une membrane cellulaire à des molécules bioactives est un enjeu majeur dans des pers...
International audienceThe ability of cell penetrating peptides (CPPs) to cross cell membranes has fo...
Cell Penetrating Peptides (CPPs) are known to be able to cross cell membranes with a cargo through t...
Les peptides vecteurs se caractérisent par leur capacité à traverser les membranes cellulaires. Ils ...
Cell penetrating peptides (CPPs) are short peptides able to efficiently cross cellular membrane. The...
Cell-penetrating peptides (CPP) are cationic oligopeptides currently investigated as potential vecto...
This document is the Accepted Manuscript version of a Published Work that appeared in final form in ...
Cell-penetrating peptides (CPPs) allow intracellular delivery of bioactive cargo molecules. The mech...
Cell penetrating peptides (CPPs) have been successfully used to mediate the intracellular delivery o...
Many biologically active compounds, including macromolecules that are used as various kinds of drugs...
Cell Penetrating Peptides (CPPs) are short amino acid sequences that are able to traverse the cell m...
Cell penetrating peptides (CPPs) are an increasingly growing part of fundamental and applied peptide...
Cell-penetrating peptides can cross cell membranes and deliver biologically active molecules into ce...
Before discovery of the Tat peptide over twenty years ago, it was assumed that large peptides and pr...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...